您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:Sotera Health Co 2024年度报告 - 发现报告

Sotera Health Co 2024年度报告

2025-04-10美股财报江***
AI智能总结
查看更多
Sotera Health Co 2024年度报告

SafeguardingGlobal Health® Our Commitmentto SafeguardingGlobal Health® Sotera Health Company (Nasdaq: SHC) is a leading global providerof mission-critical end-to-end sterilization solutions, lab testing and advisoryservices for the healthcare industry. The name Sotera Health was inspired bySoteria, the Greek goddess of safety, and reflects the Company’s unwaveringcommitment to its mission,Safeguarding Global Health®. Company Highlights Over3,000employees acrossthe globe ~5,000customers in50+ countries 90+years of sterilizationand lab services Network of62global facilities Our Three Businesses Provider of mission-critical medicaldevice and pharmaceutical lab testingand advisory services Provider of mission-critical andoften government-mandatedsterilization services ~3,000customers locations2,000+customers 12locations 48 2locations ~40customers Living Our Mission Every Day At Sotera Health, we are steadfast in our commitment to our mission,Safeguarding Global Health®.Our work helps toensure the safety of millions of patients and healthcare workers around the globe, as well as the communities in which weoperate and our 3,000+ global team members. While our high-quality testing, safe and reliable sterilization services andCobalt-60 supply expertise enable the safety of the global healthcare industry, it is our team’s commitment to living ourmission every day that makes an extraordinary difference. Our Values Alignment with UN SustainableDevelopment Goals SAFETY We are uncompromising in our commitment to healthand well-being. GoodHEALTHand well-being CUSTOMER FOCUS We are driven to fulfill our customers’ needs with thehighest quality and care. GenderEQUALITY PEOPLE We value our people who are part of a global team thatis diverse, respectful, passionate and collaborative. INTEGRITY We are honest, reliable and accountable in everythingwe do. EXCELLENCE We exceed the expectations of our stakeholders andcontinue to improve and innovate in everything we do. A Letterfrom Our CEO Dear Shareholders, Reflecting on 2024, I am proud to share thatSotera Health has continued to exemplifyour unwavering commitment to our missionof Safeguarding Global Health®. Our focus onexcellence has driven significant achievementsacross our businesses—Sterigenics, Nordion,and Nelson Labs—reinforcing our position as atrusted partner in the healthcare industry. Key financial and operational highlightsfrom 2024 include: •Consistently delivering growth, with 2024 markingthe 19thconsecutive year of annual revenue growthfor our Company; •Ongoing focus on operational excellence andreorganizing within our businesses as needed tofoster growth; •Achieving 100% fulfillment of customer Cobalt-60requests, the first time since 2018; We continue to be presented with excitingopportunities as the global economy evolvesrapidly. The rate of technological innovation offersnew avenues for growth and partnership with ourhealthcare customers, while geopolitical and supplychain disruptions help to refine our strategies andenhance our agility. However, it is the resilience ofour people that continues to make me most proud.Embracing these external factors, combined withan unrelenting focus on execution, led to anotheryear of top- and bottom-line growth. This growthunderscores the strength of our business model andour ability to deliver consistent results, all while beinguncompromising in living our core values of Safety,Customer Focus, People, Integrity and Excellence. •Welcoming Danielle Menture, Senior VicePresident, Global Environmental, Health, Safetyand Sustainability to the executive team; •Hosting our inaugural Investor Day in New York City,where we outlined our strategic position and futuregrowth plans, while providing an opportunity forenhanced shareholder engagement; •Successfully completing Term Loan and SeniorSecured Note financings to enhance our capitalstructure and support our long-term growthinitiatives; •Strengthening our Board governance with theappointment of Christopher Simon as an independentdirector in August 2024; Our focus on excellence has driven significantachievements across our businesses—Sterigenics,Nordion, and Nelson Labs—reinforcing our positionas a trusted partner in the healthcare industry. I want to take a moment to say thank you to our 3,000dedicated employees across the globe, our valuedcustomers, and you—our shareholders—for yourcontinued trust and support. We take our responsibilityseriously and we will continue to work together to makea meaningful impact in the healthcare industry anduphold our mission of Safeguarding Global Health®. •Continuing our valuable dialogue with investors throughour outreach and engagement efforts; and •Further evolving our corporate responsibility principlesand remaining steadfast in advancing our environmentalsustainability programs, improving data collectionprocesses and investing in state-of-the-art technologiesto reduce emissions across our facilit